Table 1 Differentially abundant serum proteins identified in the low and moderately-high parasitemic vivax malaria patients#.

From: Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Sl No.

Protein

Uniprot Accession ID

Unique Peptides (iTRAQ /DIGE)

Fold change HC vs. LPVM (iTRAQ/DIGE)

Fold change HC vs. MPVM (iTRAQ)

Fold change MPVM vs. LPVM (iTRAQ/DIGE)

Associated Pathways^

1

Apolipoprotein E*

P02649

12/21

1.01/3.18

1.13

1.12

Chylomicron-mediated lipid transport, HDL-mediated lipid transport, Scavenging by Class A Receptors, Retinoid metabolism and transport

2

Alpha-2-macroglobulin$

P01023

63/39

0.79

0.78

0.98/0.38

HDL-mediated lipid transport. Platelet degranulation. Intrinsic pathway of Fibrin Clot Formation. Degradation of the extracellular matrix. Rho GTPase cycle

3

Apolipoprotein A-II

P02652

7

0.72

0.48

0.66

HDL-mediated lipid transport, Chylomicron-mediated lipid transport, Scavenging by Class A Receptors, Retinoid metabolism and transport

4

Apolipoprotein A1*$

P02647

37/24

0.63

0.46

0.73/0.28–0.42

ABC transporters in lipid homeostasis, Platelet degranulation, Chylomicron-mediated lipid transport, HDL-mediated lipid transport, PPARA activates gene expression, Scavenging of heme from plasma, Scavenging by Class B Receptors, Scavenging by Class A Receptors, Retinoid metabolism and transport, Amyloids

5

Serum albumin†$

P02768

26/30

0.47

0.35

0.73/0.33–0.40

HDL-mediated lipid transport, Platelet degranulation, Recycling of bile acids and salts, Scavenging of heme from plasma and Transport of organic anions

6

Titin

Q8WZ42

2

1.69

3.77

2.23

Striated muscle contraction, Platelet degranulation

7

Gelsolin

P06396

18

0.76

0.78

1.02

Caspase-mediated cleavage of cytoskeletal proteins. Amyloid fiber formation

8

C-reactive protein

P02741

5

1.61

8.57

5.31

Classical antibody-mediated complement activation

9

Complement component C9$

P02748

5/11

1.11/3.5

1.43

1.29

Terminal pathway of complement. Regulation of Complement cascade

10

Vitronectin

P04004

6

1.05

1.12

1.07

Molecules associated with elastic fibres, Integrin cell surface interactions, Syndecan interactions, ECM proteoglycans, Regulation of Complement cascade

11

Hemoglobin subunit beta

P68871

10

1.17

1.76

1.5

Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide, Scavenging of heme from plasma, Factors involved in megakaryocyte development and platelet production

12

Hemopexin*

P02790

18/17

1.05

1.14

1.09/1.56

Scavenging of heme from plasma

13

Hemoglobin subunit alpha

P69905

7

1.05

1.52

1.45

Erythrocytes take up carbon dioxide and release oxygen. Erythrocytes take up oxygen and release carbon dioxide. Scavenging of heme from plasma

14

Glutathione peroxidase 3

P22352

2

1.03

0.69

0.67

Detoxification of reactive oxygen species

15

Haptoglobin*$

P00738

22/11

1.01/0.54

0.53

0.53/0.25–0.35

Scavenging of heme from plasma

16

Alpha-1-antitrypsin$

P01009

37/20

1.14/2.29

1.5

1.31

Platelet degranulation

17

Clusterin$

P10909

11/8

0.85

0.98

1.16/0.56–0.62

Platelet degranulation

18

Serum amyloid A-1 protein*

P0DJI8

7

1.47

1.38

0.94

RIP-mediated NFkB activation via ZBP1, Scavenging by Class B Receptors, DEx/H-box helicases activate type I IFN and inflammatory cytokines production, G alpha (q) signalling events, G alpha (i) signalling events, Formyl peptide receptors bind formyl peptides and many other ligands,TAK1 activates NFkB by phosphorylation and activation of IKKs complex, Advanced glycosylation endproduct receptor signaling, TRAF6 mediated NF-kB activation, Amyloids

19

Ig mu chain C region$

P01871

15/8

1.33/2.48

1.34

1.01

CD22 mediated BCR regulation. Antigen activates B Cell Receptor (BCR) leading to generation of second messengers

20

Ceruloplasmin$

P00450

28/18

1.17/2.33

1.37

1.17

Metal ion SLC transporters, Iron uptake and transport

21

Leucine-rich alpha-2-glycoprotein

P02750

10

1.46

1.7

1.16

22

Alpha-1-antichymotrypsin$

P01011

24/18

1.39/3.48

1.79

1.29

23

Inter-alpha-trypsin inhibitor heavy chain H4$

Q14624

24/21

1.11/2.95

1.21

1.08

24

Alpha-1B-glycoprotein$

P04217

10/16

1.00/1.89–5.1

1.15

1.15

25

Vacuolar protein sorting-associated protein 33B

Q9H267

2

0.92

1.93

2.11

26

Myelin basic protein

P02686

2

0.8

2.06

2.58

  1. #This is a partial list for a few selected candidates identified in iTRAQ and 2D-DIGE -based quantitative proteomics analysis; complete lists of the identified differentially abundant proteins are provided under supplementary information (Tables S4 and S5). ^Associated pathways obtained from Uniprot database. $Differential abundances for these candidates are also identified in 2D-DIGE (details are provided in Table S4).*Differential serum abundances of these proteins are validated by ELISA (details are provided in Table S11A). Differential abundance of serum albumin indicates the measurement of the residual HSA remained after immunodepletion.